Outlook Therapeutics (OTLK) 10-Q2020 Q2 Quarterly report

Filed: 15 May 20, 4:51pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accelerate, accelerated, agent, Aid, analyst, analyzing, assume, attain, Australian, aware, belief, broad, Brook, brought, cautionary, cease, Cedar, Center, certify, cessation, chain, chemistry, civil, clarity, CMC, confidence, confirmed, consume, consumed, controversy, country, criminal, criteria, damage, declared, deductibility, deferral, difficult, disease, display, disrupt, disrupted, disruption, Division, documentation, economy, enacted, endorsement, entirety, epidemic, evidenced, evolve, evolving, exhibit, expanded, experienced, explicit, exposure, face, faith, False, feet, fewer, forgiven, GMS, governmental, grantor, greater, health, healthcare, hearing, heightened, heightening, hereto, history, impairment, impede, impermissible, imposed, indefinitely, indirectly, ineligible, infection, inflammatory, infrastructure, institutional, interrupt, Junction, lack, lapse, lapsed, law, legislation, lifted, loan, local, located, LP, LYTENAVA, magnitude, mandating, media, medical, Monmouth, movement, national, Nonemployee, notification, ordinarily, Organization, outbreak, overcome, owed, pandemic, paramount, partner, Paycheck, penalty, perception, permanently, physical, PPP, pre, prepay, Progam, promissory, quotation, reallocation, recent, recently, recession, recurrent, regain, regaining, Relief, relocation, rely, remote, reputation, residence, resolve, rule, SBA, screen, shelter, shorter, shut, silence, site, situation, slight, Small, sponsorship, spread, square, supply, suspend, suspended, temporarily, tolled, unaffected, undue, unutilized, violated, volume, whch, wider, World, worsen

Removed: accrue, assessed, converted, default, dissolution, distinguish, employee, implement, involuntary, merger, multiplier, occurrence, participating, redeem, reorganization, restated, restructuring, sum, unpaid, voluntary, winding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

OTLK similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

.Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Outlook Therapeutics, Inc. (the “Company”) for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 15, 2020	By	/s/ Lawrence A. Kenyon
		Lawrence A. Kenyon
		Chief Executive Officer and Chief Financial Officer

“This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Outlook Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.”

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.